Integration of Metabolomics and Transcriptomics Reveals the Therapeutic Mechanism Underlying Paeoniflorin for the Treatment of Allergic Asthma.

Front Pharmacol · 2018 · PMC6362974 · PMID 30761008

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a marked trendno p-value reported

Upon metabolomic analysis, 37 metabolites in control, model and paeoniflorin groups had maintained a marked trend of “low-high-low” or “high-low-high,” such as valine, tyrosine, 9,12,15-Octadecatrienoic acid, glutamine, Leukotriene B4, and glutamic acid (Supplementary Figure S1 and Supplementary Tables S1 , S2 ).

also in 422 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.